Placebo Comparator: Placebo Control

OTHER3 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention, DiaVacs, Inc., McMaster University

Conditions

Atopic AsthmaInfluenzaOrthomyxoviridae InfectionsRespiratory Tract DiseasesRespiratory Tract InfectionsType 1 DiabetesVirus Diseases

Phase 2

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older

CompletedNCT00975572

Jiangsu Province Centers for Disease Control and PreventionInfluenza, Orthomyxoviridae Infections, Respiratory Tract Diseases +2

Start: 2009-07-31End: 2010-02-28Updated: 2012-09-12

Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy

WithdrawnNCT02354911

DiaVacs, Inc.Type 1 Diabetes

Start: 2015-10-31End: 2024-02-16Updated: 2024-02-20

Unknown Phase

Probiotics and Capsaicin Evoked Coughs

CompletedNCT03603522

McMaster UniversityAtopic Asthma

Start: 2019-07-16End: 2021-01-18Updated: 2021-03-26

Related Papers

<i>Limosilactobacillus reuteri</i> DSM‐17938 for preventing cough in adults with mild allergic asthma: A double‐blind randomized placebo‐controlled cross‐over study

Clinical & Experimental Allergy2021-07-0110 citations

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

2009-12-15176 citations

A novel influenza A (H1N1) vaccine in various age groups.

2009-10-21257 citations